Mixed influenza A and B infections complicate the detection of influenza viruses with altered sensitivities to neuraminidase inhibitors

被引:6
作者
Mohr, Peter G. [2 ]
Geyer, Henriette [1 ]
McKimm-Breschkin, Jennifer L. [1 ]
机构
[1] CSIRO Mat Sci & Engn, Parkville, Vic 3052, Australia
[2] CSIRO Livestock Ind, AAHL, Geelong, Vic 3220, Australia
关键词
Influenza A; Influenza B; Oseltamivir; Zanamivir; Mixed infections; RESISTANT; VARIANTS;
D O I
10.1016/j.antiviral.2011.04.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Previously, three influenza A(H3N2) isolates with a reduced susceptibility to the neuraminidase inhibitors (NAIs) zanamivir and oseltamivir were identified during screening by the Neuraminidase Inhibitor Susceptibility Network (NISN). The isolates were from untreated patients from the first three years post licensure of the NAIs. We plaque-purified progeny from each of these isolates and determined the NAI sensitivity of each plagued population. Sequencing and serology for each population revealed that the isolates contained a mix of wild type influenza A(H3N2) and influenza B. The NAI susceptibility reductions that had originally been reported were a consequence of influenza B neuraminidases that have lower relative NAI sensitivities, rather than being due to resistant influenza A(H3N2) viruses. Our study highlights the need to check for mixed influenza infections when isolates with potentially lower sensitivities to NAIs are identified. Crown Copyright (C) 2011 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:20 / 22
页数:3
相关论文
共 10 条
  • [1] The influenza virus resource at the national center for biotechnology information
    Bao, Yiming
    Bolotov, Pavel
    Dernovoy, Dmitry
    Kiryutin, Boris
    Zaslavsky, Leonid
    Tatusova, Tatiana
    Ostell, Jim
    Lipman, David
    [J]. JOURNAL OF VIROLOGY, 2008, 82 (02) : 596 - 601
  • [2] Dual infections by influenza A/H3N2 and B viruses and by influenza A/H3N2 and A/H1N1 viruses during winter 2007, Corsica Island, France
    Falchi, A.
    Arena, C.
    Andreoletti, L.
    Jacques, J.
    Leveque, N.
    Blanchon, T.
    Lina, B.
    Turbelin, C.
    Dorleans, Y.
    Flahault, A.
    Amoros, J. P.
    Spadoni, G.
    Agostini, F.
    Varesi, L.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2008, 41 (02) : 148 - 151
  • [3] Mixed Infection and the Genesis of Influenza Virus Diversity
    Ghedin, Elodie
    Fitch, Adam
    Boyne, Alex
    Griesemer, Sara
    DePasse, Jay
    Bera, Jayati
    Zhang, Xu
    Halpin, Rebecca A.
    Smit, Marita
    Jennings, Lance
    St George, Kirsten
    Holmes, Edward C.
    Spiro, David J.
    [J]. JOURNAL OF VIROLOGY, 2009, 83 (17) : 8832 - 8841
  • [4] Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient
    Hurt, AC
    Iannello, P
    Jachno, K
    Komadina, N
    Hampson, AW
    Barr, IG
    McKimm-Breschkin, JL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (05) : 1872 - 1874
  • [5] Neuraminidase Receptor Binding Variants of Human Influenza A(H3N2) Viruses Resulting from Substitution of Aspartic Acid 151 in the Catalytic Site: a Role in Virus Attachment?
    Lin, Yi Pu
    Gregory, Victoria
    Collins, Patrick
    Kloess, Johannes
    Wharton, Stephen
    Cattle, Nicholas
    Lackenby, Angie
    Daniels, Rodney
    Hay, Alan
    [J]. JOURNAL OF VIROLOGY, 2010, 84 (13) : 6769 - 6781
  • [6] Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir
    McKimm-Breschkin, J
    Trivedi, T
    Hampson, A
    Hay, A
    Klimov, A
    Tashiro, M
    Hayden, F
    Zambon, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) : 2264 - 2272
  • [7] Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en
    McKimmBreschkin, JL
    Blick, TJ
    Sahasrabudhe, A
    Tiong, T
    Marshall, D
    Hart, GJ
    Bethell, RC
    Penn, CR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) : 40 - 46
  • [8] Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use
    Monto, Arnold S.
    McKimm-Breschkin, Jennifer L.
    Macken, Catherine
    Hampson, Alan W.
    Hay, Alan
    Klimov, Alexander
    Tashiro, Masato
    Webster, Robert G.
    Aymard, Michelle
    Hayden, Frederick G.
    Zambon, Maria
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (07) : 2395 - 2402
  • [9] Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007
    Tashiro, Masato
    McKimm-Breschkin, Jennifer L.
    Saito, Takehiko
    Klimov, Alexander
    Macken, Catherine
    Zambon, Maria
    Hayden, Frederick G.
    [J]. ANTIVIRAL THERAPY, 2009, 14 (06) : 751 - 761
  • [10] Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: Report of the neuraminidase inhibitor susceptibility network
    Wetherall, NT
    Trivedi, T
    Zeller, J
    Hodges-Savola, C
    McKimm-Breschkin, JL
    Zambon, M
    Hayden, FG
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (02) : 742 - 750